https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-aiolos-bio/
0
0
1/9/24 at 7:06am
Organization
Gsk.com
24 words
0
Comments
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody.
You are the first to view
Create an account
or login to join the discussion